{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:46:17Z","timestamp":1785228377266,"version":"3.55.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,10,12]],"date-time":"2005-10-12T00:00:00Z","timestamp":1129075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00296-005-0059-2","type":"journal-article","created":{"date-parts":[[2005,10,11]],"date-time":"2005-10-11T10:47:56Z","timestamp":1129027676000},"page":"481-488","source":"Crossref","is-referenced-by-count":77,"title":["Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review"],"prefix":"10.1007","volume":"26","author":[{"given":"Elisa","family":"Tinazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ficarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Simeoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Artibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,10,12]]},"reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T et al (2004) Cancer statistics 2004. Cancer J Clin 54:8\u201329","journal-title":"Cancer J Clin"},{"key":"59_CR2","volume-title":"Urothelial tumors of the urinary tract","author":"EM Messing","year":"1998","unstructured":"Messing EM, Catalona W (1998) Urothelial tumors of the urinary tract. Campbell\u2019s urology, 7th edn. WB Saunders Co, Philadelphia","edition":"7"},{"key":"59_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0094-0143(05)70241-X","volume":"27","author":"G Dalbaghi","year":"2000","unstructured":"Dalbaghi G, Herr HW (2000) Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer. Urol Clin North Am 27:137\u2013146","journal-title":"Urol Clin North Am"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-5347(05)67972-4","volume":"163","author":"HW Herr","year":"2000","unstructured":"Herr HW (2000) Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year out-come. J Urol 163:60\u201362","journal-title":"J Urol"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","volume":"13","author":"HW Herr","year":"1995","unstructured":"Herr HW, Schwalb DM, Zhang ZF et al (1995) Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol 13:1404\u20131416","journal-title":"J Clin Oncol"},{"key":"59_CR6","first-page":"598","volume":"23","author":"UO Nseyo","year":"1996","unstructured":"Nseyo UO, Lamm DL (1996) Therapy of the superficial bladder cancer. Semin Oncol 23:598\u2013604","journal-title":"Semin Oncol"},{"issue":"4","key":"59_CR7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jjco\/hyh030","volume":"34","author":"CW Cheng","year":"2004","unstructured":"Cheng CW, Chan SFP, Chan LW, Chan CK, Ng CF, Cheung HY et al (2004) 15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach. Jpn J Clin Oncol 34 (4):202\u2013205","journal-title":"Jpn J Clin Oncol"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00632180","volume":"3","author":"A Morales","year":"1976","unstructured":"Morales A, Nickel JG (1976) Immunotherapy of superficial bladder cancer with BCG. World J Urol 3:209\u2013214","journal-title":"World J Urol"},{"issue":"Suppl 3","key":"59_CR9","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/314064","volume":"31","author":"DL Lamm","year":"2000","unstructured":"Lamm DL (2000) Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer. Clin Infect Dis 31 (Suppl 3):S86\u2013S90","journal-title":"Clin Infect Dis"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1464-410X.1994.tb07549.x","volume":"73","author":"RF Talic","year":"1994","unstructured":"Talic RF, Hargreave TB, Bishop MC, Kirk D, Prescott S (1994) Intravesical Evans bacille Calmette-Guerin for carcinoma in situ of the urinary bladder. Scottish Urological Oncology Group. Br J Urol 73:645\u2013648","journal-title":"Br J Urol"},{"key":"59_CR11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-5347(17)55150-2","volume":"125","author":"A Morales","year":"1981","unstructured":"Morales A, Ottenhof P, Emerson L (1981) Treatment of residual non infiltrating bladder cancer with Bacillus Calmette-Guerin. J Urol 125:649\u2013651","journal-title":"J Urol"},{"key":"59_CR12","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","volume":"325","author":"DL Lamm","year":"1991","unstructured":"Lamm DL, Blumenstein BA, Crawford ED et al (1991) A randomized trial of intravesical doxorubicin and immunotherapy with Bacillus Calmette-Guerin for transitional cell carcinoma of the bladder. N Engl J Med 325:1205\u20131209","journal-title":"N Engl J Med"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","volume":"54","author":"R Hurle","year":"1999","unstructured":"Hurle R, Losa A, Manzetti A, Lembo A (1999) Intravesical bacille Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: a 7\u00a0year follow-up. Urology 54:258\u2013263","journal-title":"Urology"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-5347(17)45604-7","volume":"135","author":"HW Herr","year":"1986","unstructured":"Herr HW, Pinsky CM, Whitemore WF, Sogani PC, Oettgen HF, Melamed MR (1986) Long term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. J Urol 135:265\u2013267","journal-title":"J Urol"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","volume":"166","author":"HW Herr","year":"2001","unstructured":"Herr HW, Sogani PC (2001) Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166:1296\u20131299","journal-title":"J Urol"},{"key":"59_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1442-2042.2004.00847.x","volume":"11","author":"A Satoh","year":"2004","unstructured":"Satoh A, Hanawa Y, Nakamura S (2004) Clinical study of bladder cancer: proteinuria as a predictor of recurrence and efficacy of intravesical bacille Calmette-Guerin therapy. Int J Urol 11:476\u2013482","journal-title":"Int J Urol"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","volume":"147","author":"DL Lamm","year":"1992","unstructured":"Lamm DL, Van der Meijden ADPM, Morales A et al (1992) Incidence and treatment of Bacillus Calmette Guerain intravesical therapy in superficial bladder cancer. J Urol 147:596\u2013600","journal-title":"J Urol"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10067-004-1063-8","volume":"24","author":"E Tinazzi","year":"2005","unstructured":"Tinazzi E, Ficarra V, Simeoni S, Peterlana D, Lunardi C (2005) Reactive arthritis following BCG immunotherapy for bladder cancer. Clin Rheumatol 24:425\u2013427","journal-title":"Clin Rheumatol"},{"key":"59_CR19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","volume":"135","author":"DL Lamm","year":"1986","unstructured":"Lamm DL, Stodgill VD, Stodgill BJ, Crispen RG (1986) Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 135:272\u2013274","journal-title":"J Urol"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/ard.48.5.432","volume":"48","author":"RA Hughes","year":"1989","unstructured":"Hughes RA, Allard SA, Maini RN (1989) Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder. Ann Rheum Dis 48:432\u2013434","journal-title":"Ann Rheum Dis"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.7326\/0003-4819-112-11-882_2","volume":"112","author":"T Ochsenkuhn","year":"1990","unstructured":"Ochsenkuhn T, Weber MM, Caselmann WH (1990) Arthritis after Mycobacterium bovis immunotherapy for bladder cancer. Ann Int Med 112:882","journal-title":"Ann Int Med"},{"key":"59_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00365599109024548","volume":"25","author":"MA al Khalifa","year":"1991","unstructured":"al Khalifa MA, Elfving P, Mansson W, Colleen S (1991) Bacillus Calmette-Guerin treatment of 39 patients with superficial transitional cell carcinoma of the bladder. Scand J Urol Nephrol 25:135\u2013139","journal-title":"Scand J Urol Nephrol"},{"key":"59_CR23","first-page":"1594","volume":"82","author":"S Kudo","year":"1991","unstructured":"Kudo S, Tsushima N, Sawadaa Y, Saito F, Motomura F, Takashima T, Kogawa T, Suzuki T, Kurotaki H, Masumori J et al (1991) Serious complications of intravesical bacillus Calmette-Guerin therapy in patients with bladder cancer. Nippon Hinyokika Gakkai Zosshi 82:1594\u20131602","journal-title":"Nippon Hinyokika Gakkai Zosshi"},{"key":"59_CR24","first-page":"37","volume":"105","author":"PT Chapman","year":"1992","unstructured":"Chapman PT, Mark SD, Moller PW (1992) Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder. N Z Med J 105:37\u201338","journal-title":"N Z Med J"},{"key":"59_CR25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1464-410X.1992.tb15808.x","volume":"70","author":"RJ Thiel Van","year":"1992","unstructured":"Van Thiel RJ, Nossent GD, Tjon Pian Gi NP (1992) Articular complications of intravesical BCG treatment for bladder carcinoma. Br J Urol 70:446\u2013447","journal-title":"Br J Urol"},{"key":"59_CR26","first-page":"1825","volume":"19","author":"P Goupille","year":"1992","unstructured":"Goupille P, Soutif D, Valat JP (1992) Arthritis after Calmette-Guerin bacillus immunotherapy for bladder cancer. J Rheumatol 19:1825\u20131826","journal-title":"J Rheumatol"},{"key":"59_CR27","first-page":"836","volume":"59","author":"P Chazerain","year":"1992","unstructured":"Chazerain P, Desplaces N, Ziza JM, Pierrot S, Cordonnier C, Chanzy M (1992) BCG osteoarthritis on knee prosthesis after intra-vesical BCG therapy. Rev Rhum Mal Osteoartic 59:836\u2013838","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"59_CR28","first-page":"162","volume":"60","author":"N Belmatoug","year":"1993","unstructured":"Belmatoug N, Levy-Djebbour S, Appelboom T et al (1993) Polyarthritis in 4 patients treated with intravesical BCG-therapy for carcinoma of the bladder. Rev Rhum Ed Fr 60:162\u2013166","journal-title":"Rev Rhum Ed Fr"},{"key":"59_CR29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/clinids\/17.3.526","volume":"17","author":"S Faus","year":"1993","unstructured":"Faus S, Martinez Montauti JM, Puig L (1993) Reiter\u2019s syndrome after administration of intravesical bacille Calmette-Guerin. Clin Infect Dis 17:526\u2013527","journal-title":"Clin Infect Dis"},{"key":"59_CR30","first-page":"503","volume":"2","author":"B Xerri","year":"1993","unstructured":"Xerri B, Chretien Y, Le Parc JM (1993) Reactive polyarthritis induced by intravesical BCG therapy for carcinoma of the bladder. Eur J Med 2:503\u2013505","journal-title":"Eur J Med"},{"key":"59_CR31","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/rheumatology\/32.11.1018","volume":"32","author":"AS Jawad","year":"1993","unstructured":"Jawad AS, Kahan L, Copland RF, Henderson DC, Abdul-Ahad AK (1993) Reactive arthritis associated with bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: a report of two cases. Br J Rheumatol 32:1018\u20131020","journal-title":"Br J Rheumatol"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/rheumatology\/32.12.1096","volume":"32","author":"P Pancaldi","year":"1993","unstructured":"Pancaldi P, Van Linthoudt D, Alberino D, Haefliger JMM, Ott H (1993) Reiter\u2019s syndrome after intravesical bacillus Calmette-Guerin treatment for superficial bladder carcinoma. Br J Rheumatol 32:1096\u20131098","journal-title":"Br J Rheumatol"},{"key":"59_CR33","first-page":"564","volume":"21","author":"GE Price","year":"1994","unstructured":"Price GE (1994) Arthritis and iritis after BCG therapy for bladder cancer. J Rheumatol 21:564\u2013565","journal-title":"J Rheumatol"},{"key":"59_CR34","first-page":"195","volume":"12","author":"P Goupille","year":"1994","unstructured":"Goupille P, Poet JL, Jattiot F, Mattei JP, Vedere V, Tonolli-Serabian J et al (1994) Three cases of arthritis after BCG therapy for bladder cancer. Clin Exp Rheumatol 12:195\u2013197","journal-title":"Clin Exp Rheumatol"},{"key":"59_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/21548331.1994.11443033","volume":"29","author":"S Varoqua","year":"1994","unstructured":"Varoqua S, Lin-Greenberg A, Brown M (1994) Polyarthritis in an elderly man with bladder cancer. Hosp Pract 29:75\u201378","journal-title":"Hosp Pract"},{"key":"59_CR36","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/bmj.308.6944.1638","volume":"308","author":"M Devlin","year":"1994","unstructured":"Devlin M, Deodhar A, Davis M (1994) Arthritis as a complication of intravesical BCG vaccine. Br Med J 308:1638","journal-title":"Br Med J"},{"key":"59_CR37","first-page":"459","volume":"62","author":"C Thepot","year":"1995","unstructured":"Thepot C, Martigny J, Simon L, Bellin J, Larget-Piet B, Chevalier X (1995) Acute polyarthritis after BCG-therapy for bladder carcinoma in a patient with ankylosing spondylitis. Rev Rhum Engl Ed 62:459\u2013461","journal-title":"Rev Rhum Engl Ed"},{"key":"59_CR38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/rheumatology\/34.11.1097","volume":"34","author":"R Queiro","year":"1995","unstructured":"Queiro R, Ballina J, Weruaga A, Fernandez JA, Rientra JL, Torre JC, Rodriguez A (1995) Psoriatic arthropathy after BCG immunotherapy for bladder cancer. Br J Rheumatol 34:1097","journal-title":"Br J Rheumatol"},{"key":"59_CR39","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1464-410X.1995.tb00788.x","volume":"76","author":"MY Hammadeh","year":"1995","unstructured":"Hammadeh MY, Dutta SN, Worraall JG, Morgan RJ (1995) Acute reactive polyarthritis after intravesical bacillus Calmette-Guerin instillation. Br J Urol 76:811\u2013812","journal-title":"Br J Urol"},{"key":"59_CR40","first-page":"1481","volume":"23","author":"P Goupille","year":"1996","unstructured":"Goupille P, Valat JP (1996) Arthritis after bacillus Calmette-Guerin therapy. J Rheumatol 23:1481\u20131482","journal-title":"J Rheumatol"},{"key":"59_CR41","first-page":"1485","volume":"23","author":"P Miossec","year":"1996","unstructured":"Miossec P (1996) Reactive arthritis associated with bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens. J Rheumatol 23:1485","journal-title":"J Rheumatol"},{"key":"59_CR42","first-page":"3231","volume":"116","author":"E Rodevand","year":"1996","unstructured":"Rodevand E, Faxvaag A, Ostensen M, Brevik B (1996) Arthritis after BCG treatment of bladder cancer. A rare complication. Tidsskr Nor Laegeforen 116:3231\u20133232","journal-title":"Tidsskr Nor Laegeforen"},{"key":"59_CR43","first-page":"752","volume":"24","author":"MD Smith","year":"1997","unstructured":"Smith MD, Chandran G, Parker, Youssef PP, Ahern M, Coleman MA et al (1997) Synovial membrane cytokine profiles in reactive arthritis secondary to intravesical bacillus Calmette-Guerin therapy. J Rheumatol 24:752\u2013758","journal-title":"J Rheumatol"},{"key":"59_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00365599709070334","volume":"31","author":"L Saporta","year":"1997","unstructured":"Saporta L, Gumus E, Karadag H, Kuran B, Miroglu C (1997) Reiter syndrome following intracavitary BCG administration. Scand J Urol Nephrol 31:211\u2013212","journal-title":"Scand J Urol Nephrol"},{"key":"59_CR45","doi-asserted-by":"crossref","first-page":"371S","DOI":"10.1042\/bst025371s","volume":"25","author":"MN Farahat","year":"1997","unstructured":"Farahat MN (1997) Selective migration of the human helper\/inducer T-cell subset (CD4+) in BCG-induced arthritis. Biochem Soc Trans 25:371S","journal-title":"Biochem Soc Trans"},{"key":"59_CR46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/00365599709070359","volume":"31","author":"CP Hansen","year":"1997","unstructured":"Hansen CP, Mortensen S (1997) Epididimo-orchitis and Reiter\u2019s disease. Two infrequent complications after intravesical bacillus Calmette-Guerin therapy. Scand J Urol Nephrol 31:317\u2013318","journal-title":"Scand J Urol Nephrol"},{"key":"59_CR47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/cs0950019","volume":"95","author":"JS Gaston","year":"1998","unstructured":"Gaston JS (1998) Role of T-cells in the development of arthritis. Clin Sci 95:19\u201331","journal-title":"Clin Sci"},{"key":"59_CR48","first-page":"475","volume":"27","author":"L Fond","year":"1998","unstructured":"Fond L, Bencharif L, Guglielminotti C, Lauwers A, Lucht F (1998) Acute oligo-arthritis in a patient treated with BCG therapy for bladder carcinoma. Presse Med 27:475","journal-title":"Presse Med"},{"key":"59_CR49","first-page":"106","volume":"66","author":"L Milas","year":"1999","unstructured":"Milas L, Maillefert JF, Michel F, Piroth C, Wautot A, Tavernier C (1999) Refractory arthropathy after intravesical bacillus Calmette-Guerin therapy. Usefulness of isoniazide. Rev Rhum Engl Ed 66:106\u2013108","journal-title":"Rev Rhum Engl Ed"},{"key":"59_CR50","first-page":"115","volume":"66","author":"G Clavel","year":"1999","unstructured":"Clavel G, Grados F, Cayrolle G, Bellony R, Leduc I, Lafont B, Ducroix JP, Fardellone P (1999) Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature. Rev Rhum Engl Ed 66:115\u2013118","journal-title":"Rev Rhum Engl Ed"},{"key":"59_CR51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s100670050059","volume":"18","author":"O Onur","year":"1999","unstructured":"Onur O, Celiker R (1999) Polyarthritis as a complication of intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer. Clin Rheumatol 18:74\u201376","journal-title":"Clin Rheumatol"},{"key":"59_CR52","first-page":"933","volume":"26","author":"JM Schwartzenberg","year":"1999","unstructured":"Schwartzenberg JM, Smith DD, Lindsley HB (1999) Bacillus Calmette-Guerin associated arthropathy mimicking undifferentiated spondyloarthropathy. J Rheumatol 26:933\u2013935","journal-title":"J Rheumatol"},{"key":"59_CR53","first-page":"1011","volume":"26","author":"G Chevrel","year":"1999","unstructured":"Chevrel G, Zech C, Miossec P (1999) Severe uveitis followed by reactive arthritis after bacillus Calmette-Guerin therapy. J Rheumatol 26:1011","journal-title":"J Rheumatol"},{"key":"59_CR54","first-page":"29","volume":"5","author":"GI Varentsov","year":"1999","unstructured":"Varentsov GI, Zakhmatov IuM, Kornev AI, Otvetchikov IN (1999) Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer. Urologia 5:29\u201330","journal-title":"Urologia"},{"key":"59_CR55","first-page":"225","volume":"2","author":"A Aharon-Maor","year":"2000","unstructured":"Aharon-Maor A, Shoenfeld Y (2000) The good, the bad and the ugly of vaccination. Isr Med Assoc J 2:225\u2013227","journal-title":"Isr Med Assoc J"},{"key":"59_CR56","first-page":"240","volume":"2","author":"I Hodish","year":"2000","unstructured":"Hodish I, Ezra D, Gur H, Strego R, Olchovsky D (2000) Reiter\u2019s syndrome after intravesical bacillus Calmette-Guerin therapy for bladder cancer. Isr Med Assoc J 2:240\u2013241","journal-title":"Isr Med Assoc J"},{"key":"59_CR57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/pgmj.76.902.791","volume":"76","author":"MB Hogarth","year":"2000","unstructured":"Hogarth MB, Thomas S, Seifert MH, Tariq SM (2000) Reiter\u2019s syndrome following intravesical BCG therapy. Postgrad Med J 76:791\u2013793","journal-title":"Postgrad Med J"},{"key":"59_CR58","first-page":"1699","volume":"28","author":"S Mouly","year":"2001","unstructured":"Mouly S, Berenbaum F, Kaplan G (2001) Remitting seronegative symmetrical synovitis with pitting edema following intravesical bacillus Calmette-Guerin instillation. J Rheumatol 28:1699\u20131701","journal-title":"J Rheumatol"},{"key":"59_CR59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/jaut.2000.0494","volume":"16","author":"Y Shoenfeld","year":"2001","unstructured":"Shoenfeld Y, Aron-Maor A, Tanai A, Ehrenfeld M (2001) BCG and autoimmunity: another two-edged sword. J Autoimmun 16:235\u2013240","journal-title":"J Autoimmun"},{"key":"59_CR60","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1055\/s-2002-34066","volume":"127","author":"C Neumayr","year":"2002","unstructured":"Neumayr C, Kirchgatterer A, Knoflach P (2002) Chronic reactive arthritis associated with Calmette-Guerin bacillus. Dtsch Med Wochenschr 127:1886\u20131888","journal-title":"Dtsch Med Wochenschr"},{"key":"59_CR61","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s100670200131","volume":"21","author":"NP Pardalidis","year":"2002","unstructured":"Pardalidis NP, Papatsoris AG, Kosmaoglou EV, Georganas C (2002) Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer. Clin Rheumatol 21:536\u2013537","journal-title":"Clin Rheumatol"},{"key":"59_CR62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/rheumatology\/41.10.1119","volume":"41","author":"MJ Bartolome Pacheco","year":"2002","unstructured":"Bartolome Pacheco MJ, Martinez-Taboada VM, Blanco R, Rodriguez-Valverde V, Valle JI, Lopez-Hoyos M (2002) Reactive arthritis after BCG immunotherapy: T cell analysis in peripheral blood and synovial fluid. Rheumatology 41: 1119\u20131125","journal-title":"Rheumatology"},{"key":"59_CR63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1297-319X(01)00350-5","volume":"69","author":"AJ Mas","year":"2002","unstructured":"Mas AJ, Romera M, Valverde-Garcia JM (2002) Articular manifestations after the administration of intravesical BCG. Joint Bone Spine 69:92\u201393","journal-title":"Joint Bone Spine"},{"key":"59_CR64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1157\/13050829","volume":"121","author":"JM Pego","year":"2003","unstructured":"Pego JM, Lamas C, Hernandez I, Suso J (2003) Relapsing Reiter\u2019s syndrome after bacillus Calmette-Guerin immunotherapy for bladder carcinoma. Med Clin 121:356\u2013357","journal-title":"Med Clin"},{"key":"59_CR65","first-page":"599","volume":"49","author":"M Shiba","year":"2003","unstructured":"Shiba M, Fujii T, Takatera H (2003) Reiter syndrome after intravesical bacillus Calmette-Guerin (BCG) immunotherapy: a case report. Hinyokika Kiyo 49:599\u2013601","journal-title":"Hinyokika Kiyo"},{"key":"59_CR66","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9343(03)00398-X","volume":"115","author":"J Narvaez","year":"2003","unstructured":"Narvaez J, Castro-Bohorquez FJ, Vilaseca-Momplet J (2003) Sjogren\u2019s-like syndrome following intravesical bacillus Calmette-Guerin immunotherapy. Am J Med 115:418\u2013419","journal-title":"Am J Med"},{"key":"59_CR67","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1078-1439(03)00012-7","volume":"21","author":"JS Lam","year":"2003","unstructured":"Lam JS, Benson MC, O\u2019Donnell MA, Sawczuk A, Gavazzi A, Wechsler MH et al (2003) Bacillus Calmette-Guerin plus interferon-\u03b12B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity. Urol Oncol 21:354\u2013360","journal-title":"Urol Oncol"},{"key":"59_CR68","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","volume":"147","author":"S Prescott","year":"1992","unstructured":"Prescott S, James K, Hargreave TB, Chisholm GD, Smyth JF (1992) Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol 147:1636\u20131642","journal-title":"J Urol"},{"key":"59_CR69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.1995.tb05560.x","volume":"99","author":"AM Jackson","year":"1995","unstructured":"Jackson AM, Alexandroff AB, Kelly RW, Skibinska A, Esuvaranathan K, Prescott S et al (1995) Changes in urinary cytokines and solubile intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guerin (BCG) immunotherapy. Clin Exp Immunol 99:369\u2013375","journal-title":"Clin Exp Immunol"},{"key":"59_CR70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","volume":"21","author":"Y Luo","year":"2003","unstructured":"Luo Y, Chen X, O\u2019Donnell MA (2003) Role of Th1 and Th2 cytokines in BCG-inbuced IFN-\u03b3 production: cytokine promotion and stimulation of BCG effect. Cytokine 21:17\u201326","journal-title":"Cytokine"},{"key":"59_CR71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.cgt.7700083","volume":"7","author":"I Hara","year":"2000","unstructured":"Hara I, Nagai H, Miyake H et al (2000) Effectiveness of cancer vaccine therapy using cells transduced with the interleukine-12 gene combined with systemic interleukin-18 administration. Cancer Gene Ther 7:83\u201390","journal-title":"Cancer Gene Ther"},{"key":"59_CR72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/07357900009031825","volume":"18","author":"H Nagai","year":"2000","unstructured":"Nagai H, Hara I, Horikawa T et al (2000) Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. Cancer Invest 18:206\u201313","journal-title":"Cancer Invest"},{"key":"59_CR73","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0022-5347(05)65522-X","volume":"166","author":"F Saint","year":"2001","unstructured":"Saint F, Patard JJ, Maille P, Soyeux P, Hoznek A, Salomon L et al (2001) T-helper 1\/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer. J Urol 166:2142\u20132147","journal-title":"J Urol"},{"key":"59_CR74","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00002371-200403000-00005","volume":"27","author":"J Arnold","year":"2004","unstructured":"Arnold J, de Boer EC, O\u2019Donnell MA, Bohle A, Brandau S (2004) Immunotherapy of experimental bladder cancer with recombinant BCG expressing Interferon-gamma. J Immunother 27:116\u2013123","journal-title":"J Immunother"},{"key":"59_CR75","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.urology.2003.09.039","volume":"63","author":"DS Yu","year":"2004","unstructured":"Yu DS, Lee CF, Hsieh DS, Chang SY (2004) Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer. Urology 63:596\u2013601","journal-title":"Urology"},{"key":"59_CR76","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","volume":"6","author":"C Lunardi","year":"2000","unstructured":"Lunardi C, Bason C, Navone R et al (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183\u20131186","journal-title":"Nat Med"},{"key":"59_CR77","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/art.1780070111","volume":"7","author":"CM Pearson","year":"1964","unstructured":"Pearson CM (1964) Experimental models in rheumatoid disease. Arthritis Rheum 7:80\u201386","journal-title":"Arthritis Rheum"},{"key":"59_CR78","first-page":"1662","volume":"25","author":"N Buchs","year":"1998","unstructured":"Buchs N, Chevrel G, Miossec P (1998) Bacillus Calmette-Guerin induced aseptic arthritis: an experimental model of reactive arthritis. J Rheumatol 25:1662\u20131665","journal-title":"J Rheumatol"},{"key":"59_CR79","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.4049\/jimmunol.162.7.3830","volume":"162","author":"N Dulphy","year":"1999","unstructured":"Dulphy N, Peyrat M-A, Tieng V et al (1999) Common intra-articular T cell expansions in patients with reactive arthritis: identical \u03b1-chain junctional sequences and cytotoxicity toward HLA-B27. J Immunol 162:3830\u20133839","journal-title":"J Immunol"},{"key":"59_CR80","first-page":"255","volume":"66","author":"Y Shoenfeld","year":"1986","unstructured":"Shoenfeld Y, Vilner Y, Coates ARM, Rauch J, Shaul D, Pinkhas J (1986) Monoclonal antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255\u2013261","journal-title":"Clin Exp Immunol"},{"key":"59_CR81","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0021-9681(70)90047-0","volume":"22","author":"KJ Lindqvist","year":"1997","unstructured":"Lindqvist KJ, Coleman RE, Osterland CK (1997) Autoantibodies in chronic pulmonary tuberculosis. J Chron Dis 22:717\u2013725","journal-title":"J Chron Dis"},{"key":"59_CR82","first-page":"323","volume":"61","author":"CJ Thorns","year":"1985","unstructured":"Thorns CJ, Morris JA (1985) Common epitopes between mycobacteria and certain host tissue antigens. Clin Exp Immunol 61:323\u2013328","journal-title":"Clin Exp Immunol"},{"key":"59_CR83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0022-510X(82)90042-9","volume":"57","author":"P Glynn","year":"1982","unstructured":"Glynn P, Weedon D, Edwards J, Suckling AJ, Cuzner ML (1982) Humoral immunity in chronic relapsing experimental autoimmune encephalomyelitis. The major oligoclonal IgG bands are antibodies to mycobacteria. Neurol Sci 57:369\u2013384","journal-title":"Neurol Sci"},{"key":"59_CR84","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.82.15.5117","volume":"82","author":"W Eden Van","year":"1985","unstructured":"Van Eden W, Holoshitz J, Nevo A, Frenkel A, Klajman A, Cohen IR (1985) Arthritis induced by a T-lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117\u20135120","journal-title":"Proc Natl Acad Sci USA"},{"key":"59_CR85","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1464-410X.1989.tb05187.x","volume":"63","author":"S Prescott","year":"1989","unstructured":"Prescott S, James K, Busuttil A, Hargreave TB, Chisholm GD, Smyth JF (1989) HLA-DR expression by high grade superficial bladder cancer treated with BCG. Br J Urol 63:264\u2013269","journal-title":"Br J Urol"},{"key":"59_CR86","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(03)14075-5","volume":"362","author":"AG Pockley","year":"2003","unstructured":"Pockley AG (2003) Heat shock proteins as regulators of the immune response. Lancet 362:469\u2013476","journal-title":"Lancet"},{"key":"59_CR87","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1471-4906(01)02089-0","volume":"22","author":"G Wick","year":"2001","unstructured":"Wick G, Perschinka, Millonig G (2001) Atherosclerosis as an autoimmune disease: an update. Trends Immunol 22:665\u2013669","journal-title":"Trends Immunol"},{"key":"59_CR88","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/eji.1830250222","volume":"25","author":"U Zugel","year":"1999","unstructured":"Zugel U, Schoel B, Yamamoto S, Hengel H, Morein B, Kaufmann SH (1999) Crossrecognition by CD8 T cell receptor \u03b1\u03b2 cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur J Immunol 25:451\u2013458","journal-title":"Eur J Immunol"},{"key":"59_CR89","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1348-0421.2004.tb03525.x","volume":"48","author":"I Hara","year":"2004","unstructured":"Hara I, Sato N, Miyake H, Muramaki M, Hikosaka S, Kamidono S (2004) Introduction of 65\u00a0kDa antigen of Mycobacterium tuberculosis to cancer cells enhances anti-tumor effect of BCG therapy. Microbiol Immunol 48:289\u2013295","journal-title":"Microbiol Immunol"},{"key":"59_CR90","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0022-5347(17)36973-2","volume":"148","author":"LC Boer de","year":"1992","unstructured":"de Boer LC, Steerenberg PA, van der Meijen APM et al (1992) Impaired immune response by Isoniazid treatment during intravesical BCG administration in the guinea pig. J Urol 148:1577\u20131582","journal-title":"J Urol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0059-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0059-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0059-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T01:49:37Z","timestamp":1683251377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0059-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0059-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,12]]}}}